China Resources Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 8% in H1

MT Newswires Live

Aug 24

China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) attributable profit fell nearly 8% to 1.67 billion yuan in the first half from 1.82 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen Stock Exchange.

Earnings per share at the pharmaceutical company decreased to 1 yuan from 1.09 yuan in the prior-year period.

Operating revenue edged up 1.4% year over year to 15 billion yuan from 14.8 billion yuan.

Directors declared a dividend of 4.15 yuan per 10 shares or 0.415 yuan per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/news/2661295682"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2661295682\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2661295682?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 15:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661295682","market":"nz","top_or_hot":-1,"title":"China Resources Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 8% in H1","media":"MT Newswires Live","content":"<html><body><p> China Resources Sanjiu Medical &amp; Pharmaceutical (SHE:000999) attributable profit fell nearly 8% to 1.67 billion yuan in the first half from 1.82 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen Stock Exchange.</p><p>Earnings per share at the pharmaceutical company decreased to 1 yuan from 1.09 yuan in the prior-year period.</p><p>Operating revenue edged up 1.4% year over year to 15 billion yuan from 14.8 billion yuan.</p><p>Directors declared a dividend of 4.15 yuan per 10 shares or 0.415 yuan per share.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Resources Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 8% in H1</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Resources Sanjiu Medical & Pharmaceutical's Attributable Profit Slides 8% in H1\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-08-24 15:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> China Resources Sanjiu Medical &amp; Pharmaceutical (SHE:000999) attributable profit fell nearly 8% to 1.67 billion yuan in the first half from 1.82 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen Stock Exchange.</p><p>Earnings per share at the pharmaceutical company decreased to 1 yuan from 1.09 yuan in the prior-year period.</p><p>Operating revenue edged up 1.4% year over year to 15 billion yuan from 14.8 billion yuan.</p><p>Directors declared a dividend of 4.15 yuan per 10 shares or 0.415 yuan per share.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661295682","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661295682","pubTimestamp":1787557271,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"China Resources Sanjiu Medical & Pharmaceutical  attributable profit fell nearly 8% to 1.67 billion yuan in the first half from 1.82 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen Stock Exchange.Earnings per share at the pharmaceutical company decreased to 1 yuan from 1.09 yuan in the prior-year period.Operating revenue edged up 1.4% year over year to 15 billion yuan from 14.8 billion yuan.Directors declared a dividend of 4.15 yuan per 10 shares or 0.415 yuan per share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0175":"白马股","BK0196":"行业龙头","BK0060":"抗癌","FCA":"First Trust China AlphaDEX Fund","BK0010":"央企","BK0028":"国家队","000999":"华润三九","BK0185":"二线龙头","BK0239":"医药制造","BK0183":"MSCI概念","BK0188":"融资融券","BK0012":"证金概念"},"translate_title":"华润三九医药上半年应占利润下滑8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"000999":0.9,"FCA":0.9},"content_text":"China Resources Sanjiu Medical & Pharmaceutical (SHE:000999) attributable profit fell nearly 8% to 1.67 billion yuan in the first half from 1.82 billion yuan in the year-ago period, according to a Saturday filing with the Shenzhen Stock Exchange.Earnings per share at the pharmaceutical company decreased to 1 yuan from 1.09 yuan in the prior-year period.Operating revenue edged up 1.4% year over year to 15 billion yuan from 14.8 billion yuan.Directors declared a dividend of 4.15 yuan per 10 shares or 0.415 yuan per share.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}